Hjem › Larynxcancer
Kliniske studier for Larynxcancer rekrutterer i USA
26 studier for Larynxcancer rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Milwaukee, WI8 studier
- Atlanta, GA8 studier
- Chicago, IL8 studier
- Kansas City, MO7 studier
- St. Louis, MO7 studier
- Edison, NJ6 studier
- Pittsburgh, PA6 studier
- Durham, NC6 studier
- Portland, OR6 studier
- Baltimore, MD6 studier
- Cincinnati, OH6 studier
- Richmond, VA6 studier
- New York City, NY5 studier
- Queens, NY5 studier
- Kansas City, KS5 studier
- Naperville, IL5 studier
- Omaha, NE5 studier
- Philadelphia, PA5 studier
- Oklahoma City, OK5 studier
- Ann Arbor, MI5 studier
- Champaign, IL5 studier
- Charleston, IL5 studier
- Danville, IL5 studier
- Overland Park, KS5 studier
- Irvine, CA5 studier
- Cedar Rapids, IA5 studier
- Duluth, MN5 studier
- Fargo, ND5 studier
- Lansing, MI5 studier
- Stevens Point, WI5 studier
- Joliet, IL5 studier
- Peoria, IL5 studier
- Bloomington, IL5 studier
- Wausau, WI5 studier
- Cape Girardeau, MO5 studier
- O'Fallon, MO4 studier
- Erie, PA4 studier
- Des Moines, IA4 studier
- Los Angeles, CA4 studier
- Little Rock, AR4 studier
Etter delstat
- Arizona5 studier
- Arkansas5 studier
- California9 studier
- Colorado7 studier
- Connecticut3 studier
- Delaware3 studier
- Florida8 studier
- Georgia8 studier
- Idaho4 studier
- Illinois9 studier
- Indiana4 studier
- Iowa8 studier
- Kansas7 studier
- Kentucky3 studier
- Louisiana4 studier
- Maryland7 studier
- Massachusetts7 studier
- Michigan6 studier
- Minnesota7 studier
- Mississippi3 studier
- Missouri9 studier
- Montana5 studier
- Nebraska5 studier
- New Hampshire3 studier
- New Jersey7 studier
- New Mexico3 studier
- New York10 studier
- North Carolina8 studier
- North Dakota5 studier
- Ohio11 studier
- Oklahoma6 studier
- Oregon6 studier
- Pennsylvania9 studier
- South Carolina5 studier
- South Dakota3 studier
- Tennessee3 studier
- Texas5 studier
- Virginia7 studier
- Washington3 studier
- Wisconsin9 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06997068Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07195734BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT05136196Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06980038Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07441681Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jul. 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 23. apr. 2026 · NCT07209189Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 15. apr. 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 4. mar. 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 19. feb. 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. feb. 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 10. feb. 2026 · NCT01473784CONFIRM: Magnetic Resonance Guided Radiation Therapy
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 9. feb. 2026 · NCT04368702Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 11. des. 2025 · NCT05793151Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 26. nov. 2025 · NCT06080503SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. okt. 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
RekruttererObservasjonsstudie
Alder 21 til 90 · Alle kjønn · Oppdatert 22. sep. 2025 · NCT00900419Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.